Analysis: Mounting Pressure on China About Covid ‘Lab Leak’ Could Backfire
Where the coronavirus originated remains a mystery and the Chinese are bucking demands to let investigators see more.
All Coverage
-
-
FDA Weighs Approval of a Lucrative Alzheimer’s Drug, but Benefits Are Iffy
The agency is to decide by June 7 whether to greenlight Biogen’s drug aducanumab, despite a near-unanimous rejection of the product by an FDA advisory committee of outside experts in November. Some scientists at the agency have endorsed the drug, though.
-
KHN’s ‘What the Health?’: The Drug Price Dilemma
Republicans, Democrats and the public at large agree that prices for prescription drugs are too high. But no one seems to know how to fix it. Vanderbilt University drug price researcher Stacie Dusetzina explains the basics of why drugs cost so much and why it’s hard to do something about it. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the prospects for policy changes.
-
Many New Moms Get Kicked Off Medicaid 2 Months After Giving Birth. Illinois Will Change That.
Each year, hundreds of thousands of new mothers lose Medicaid coverage after 60 days when their income exceeds limits. But deadly childbirth complications persist months longer.
-
Newsom Wants to Spend Millions on the Health of Low-Income Mothers and Their Babies
Democratic legislators back measures that would end the “pink tax” on diapers and menstrual products, provide mental health support, and pilot a guaranteed-income program.
-
Expanding Insurance Coverage Is Top Priority for New Medicare-Medicaid Chief
Chiquita Brooks-LaSure, the new head of the Centers for Medicare & Medicaid Services, said the administration will focus on getting more people insured and is interested in finding a way to alleviate the gap keeping low-income families in states that haven’t expanded Medicaid from enrolling in Affordable Care Act health plans.
-
Covid’s Long Shadow: Mourning in America
The ‘Grief Pandemic’ Will Torment Americans for Years
More than 5 million Americans lost a loved one to covid, and the ripple effects could lead to serious illness down the road.
-
Doctors Tell How to Make the Most of Your Telehealth Visits
Public health restrictions put in place during the pandemic are loosening, meaning it’s OK to go back to your doctor’s office. But will virtual visits remain an option?
-
Readers and Tweeters React to Racism, Inequities in Health Care
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Q&A
From Racial Justice to Dirty Air, California’s New AG Plots a Progressive Health Care Agenda
In a candid interview, California’s newly appointed attorney general, Rob Bonta, reflects on his progressive roots and says he will pursue a health care agenda centered on the principle that quality medical care is a right, not a privilege.
-
Little-Known Illnesses Turning Up in Covid Long-Haulers
A significant number of post-covid patients suffer from syndromes that few doctors understand.
-
Behind The Byline: Finding a ‘Superstar’ to Interview
Check out KHN’s video series — Behind The Byline: How the Story Got Made. Come along as journalists and producers offer an insider’s view of health care coverage that does not quit.
-
Mississippi’s Black Communities Turned Around Their Covid Rates. Next Up: Make Strides on Vaccines.
Covid-19 tore through Mississippi’s Black population in the pandemic’s early days, but community efforts slowed the rate. Now health officials and community leaders aim to replicate the success as they dole out vaccines.
-
KHN Journalist Combs for Clues on Covid’s Origins
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
-
Biden Administration Signals It’s in No Rush to Allow Canadian Drug Imports
Federal officials asked a court to dismiss a suit by drugmakers over the policy enacted by the Trump administration that would allow states to bring in cheaper prescription medications from Canada. The filing said the lawsuit was moot because it’s unclear when or if the FDA would approve any state’s importation plan.
-
Data Visualizations
Caring for an Aging Nation
The number of Americans 65 and older is expected to nearly double in the next 40 years. Finding a way to provide and pay for the long-term health services they need won’t be easy.
-
Opioids Like ‘Lean’ Permeate Hip-Hop Culture, but Dangers Are Downplayed
In big cities and small towns, opioid use among some young hip-hop fans is about emulating their favorite rap star’s image — while paying little attention to the serious consequences.
-
In California, Nursing Home Owners Can Operate After They’re Denied a License
Nursing home chain ReNew Health continues to care for hundreds of patients even after the state attempted to crack down. Before and during the pandemic, homes connected to ReNew had safety violations.
-
KHN’s ‘What the Health?’: The Return of the Public Option
Lawmakers are working on fleshing out the concept of a “public option,” a government-run or heavily regulated insurance plan that would compete with private insurance. But the details are complicated, both substantively and politically. Meanwhile, bioethicists are debating whether the U.S. should be vaccinating low-risk adolescents against covid-19 while high-risk adults in other countries are still waiting. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
Q&A
Confronting Our ‘Frailties’: California’s Assembly Leader Reflects on a Year of Covid
California Assembly Speaker Anthony Rendon says covid exposed long-standing health care inequities that must be addressed. He told KHN he wants to get more people insured, boost broadband access so more patients can use telehealth and increase funding to local health departments.
